US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 0.6633
  • -0.0212-3.10%
Close May 8 16:00 ET
  • 0.6800
  • +0.0167+2.52%
Post 19:56 ET
119.74MMarket Cap-2551P/E (TTM)

About Citius Pharmaceuticals Company

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Company Profile

SymbolCTXR
Company NameCitius Pharmaceuticals
Listing DateAug 3, 2017
Issue Price4.13
Founded2007
CEOMr. Leonard L. Mazur
MarketNASDAQ
Employees22
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address11 Commerce Drive,1st floor
CityCranford
ProvinceNew Jersey
CountryUnited States of America
Zip Code07016
Phone1-908-967-6677
Websitehttp://www.citiuspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Leonard L. Mazur
  • Executive Chairman of the Board, Chief Executive Officer and Secretary; Secretary of NoveCite, Inc. and President and Chief Executive Officer of Citius Oncology, Inc.
  • 1.98M
  • Jaime Bartushak
  • Chief Financial Officer, Chief Accounting Officer and Chief Business Officer
  • 514.51K
  • Dr. Myron Czuczman
  • Chief Medical Officer and Executive Vice President
  • 1.17M
  • Myron Z. Holubiak
  • Executive Vice Chairman of the Board
  • 1.59M
  • Dennis M. McGrath, C.P.A.
  • Independent Director
  • 150.13K
  • Dr. Eugene Holuka
  • Independent Director
  • 190.97K
  • Carol Webb
  • Independent Director
  • 190.97K
  • Robert J. Smith
  • Independent Director
  • --
  • Suren G. Dutia
  • Lead Independent Director
  • 196.97K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg